Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$88.71 - $120.43 $150,629 - $204,490
1,698 Added 24.44%
8,646 $865,000
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $142,327 - $190,456
1,441 Added 26.17%
6,948 $869,000
Q2 2020

Jul 30, 2020

BUY
$60.49 - $97.5 $15,243 - $24,570
252 Added 4.8%
5,507 $447,000
Q1 2020

May 13, 2020

BUY
$59.04 - $88.81 $310,255 - $466,696
5,255 New
5,255 $366,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.97B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.